Delivering pulmonary rehabilitation via telehealth during COVID-19
Read more of the post Delivering pulmonary rehabilitation via telehealth during COVID-19l
Advancing research and improving health for people with respiratory conditions
By developing new, and supporting existing, collaborations from across the Partnership, we aim to support the implementation of evidence into practice that will ensure respiratory patients receive the highest level of evidence-based care.
Now entering its third year, the Network combines clinicians from all facets of respiratory care, from specialist physicians to physiotherapists and pharmacists. Four sub-groups work together to generate ideas within sub-specialties:
Establishing a platform for a series of community-based trials of treatments for the virus
Professor Guy Marks, Head of the Woolcock’s Respiratory and Environmental Epidemiology Group, is leading this project in collaboration with the clinical trials centre which will expand over time to link to projects across the nation and internationally, in the UK and New Zealand.
Projects looking at the immune response in patients, contacts and healthcare workers
Woolcock epidemiologist Associate Professor Greg Fox (also at the University of Sydney and SLHD) has been working on COVID-19 modelling in collaboration with Royal Prince Alfred Hospital. He is also leading a project to study COVID-19 in Vietnam, where the Woolcock has an established research base.
Developing novel COVID-19 therapies for the upper and lower respiratory tract; Investigating how to ‘Cap’ COVID-19 to ‘cloak’ this virus, making it ineffective
Professor Paul Young, Professor Daniela Traini and Dr Hui Xin Ong from the Respiratory Technology group, Woolcock and the University of Sydney are collaborating with colleagues from the University, a number of international pharmaceutical companies as well as with Canadian researchers.
The COPD sub-group have been working to deliver consolidated data on the value of pulmonary rehab to prevent hospitalisations in Australia. It draws from hospital data about patients throughout Australia who have received pulmonary rehabilitation.
Pulmonary rehabilitation involves exercise training and behavioural therapies designed to improve how people with chronic lung disease function in daily life. While there is international evidence on the value of pulmonary rehabilitation in preventing hospitalisations, no studies have been conducted in Australia at this scale.
The Respiratory Technology team at the Woolcock will be involved in exciting new research in the fight against COVID-19 following the announcement of a $15-million investment by the State Government to be led by the newly-formed NSW RNA Production and Research Network.
Read more of the post Woolcock Researchers Join a New Front in the Fight Against COVID
Woolcock Executive Director Professor Carol Armour has been awarded one of Australia’s most coveted science gongs for her work mentoring young scientists.
Read more of the post Woolcock Executive Director Awarded Eureka Prize for Outstanding Mentorship of Young Researchers
Respiratory clinicians have been meeting under SHP’s ‘Themes and Streams’ model in a cross-institutional collaboration that works together to advance research and improve health for people with respiratory conditions. Now entering its third year, the theme combines clinicians from all facets of respiratory care, from specialist respiratory physicians to physiotherapists and pharmacists. Co-led by Professor … Read more
Read more of the post Sydney Health Partners Boosts Clinician-led Respiratory Research